Tags

Type your tag names separated by a space and hit enter

Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
Cancer Res. 1974 Aug; 34(8):1857-61.CR

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

4842737

Citation

Razek, A, et al. "Optimum Time Sequence for the Administration of Vincristine and Cyclophosphamide in Vivo." Cancer Research, vol. 34, no. 8, 1974, pp. 1857-61.
Razek A, Vietti T, Valeriote F. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo. Cancer Res. 1974;34(8):1857-61.
Razek, A., Vietti, T., & Valeriote, F. (1974). Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo. Cancer Research, 34(8), 1857-61.
Razek A, Vietti T, Valeriote F. Optimum Time Sequence for the Administration of Vincristine and Cyclophosphamide in Vivo. Cancer Res. 1974;34(8):1857-61. PubMed PMID: 4842737.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo. AU - Razek,A, AU - Vietti,T, AU - Valeriote,F, PY - 1974/8/1/pubmed PY - 1974/8/1/medline PY - 1974/8/1/entrez SP - 1857 EP - 61 JF - Cancer research JO - Cancer Res VL - 34 IS - 8 SN - 0008-5472 UR - https://www.unboundmedicine.com/medline/citation/4842737/Optimum_time_sequence_for_the_administration_of_vincristine_and_cyclophosphamide_in_vivo_ L2 - http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=4842737 DB - PRIME DP - Unbound Medicine ER -